One-year-old conjoined twins Minal and Mirha from Pakistan were successfully separated during a 14-hour surgery at Ankara Bilkent City Hospital on July 19, 2024. Led by British surgeon Professor Noor ul Owase Jeelani, the complex procedure utilized mixed reality technology to guide the separation. The twins, who were joined at the head and shared vital brain tissue and blood vessels, are recovering well and expected to return home next month. Supported by the charity Gemini Untwined, the operation marks a significant achievement in separating craniopagus twins.

Kerala’s Health Minister Veena George confirmed a case of mpox in Malappuram, involving a 38-year-old man who recently returned from the UAE. The patient is currently undergoing treatment, and isolation facilities have been established in hospitals across the state. George urged individuals traveling from other countries to report any mpox symptoms and seek immediate medical assistance. Over 103,000 mpox cases have been reported globally across 120 countries, with Kerala continuing its vigilant monitoring. Phone numbers of nodal officers for the health department have been shared for assistance in managing the outbreak.

independent probe into the 2021 death of 27-year-old Jack Last has revealed significant NHS failings. Last died from a blood clot after receiving the AstraZeneca COVID-19 vaccine, despite being ineligible due to his age. His GP mistakenly called him up early for vaccination, denying him a safer alternative recommended for under-30s. The report attributed Last's death to "a combination of system shortcomings, human error, and tragic unfortunate timing," highlighting the need for improved vaccine administration protocols. The findings have led Last's family to accuse the NHS of a "litany of errors" that cost a young life.

A suspected case of mpox has been reported in Kerala’s Malappuram district. A man, who recently returned from abroad, showed symptoms of the virus and was admitted to Manjeri Medical College. His samples have been sent to Kozhikode Medical College for testing. This comes after a confirmed mpox case was reported last week in Delhi, where a 26-year-old from Haryana tested positive. The World Health Organization (WHO) declared mpox a Public Health Emergency of International Concern last month, given its spread across Africa. Mpox symptoms include fever, rash, and swollen lymph nodes.

The World Health Organization (WHO) has prequalified the MVA-BN vaccine as the first mpox vaccine, enhancing access to vital immunization against the disease. Approved for individuals over 18, the vaccine is administered in two doses, four weeks apart. It can be stored at 2-8°C for up to eight weeks. The WHO emphasizes urgent procurement and distribution to tackle ongoing outbreaks, particularly in Africa. While the vaccine is not licensed for those under 18, it may be used "off-label" in high-risk outbreak settings. Data shows the vaccine's effectiveness at 76% for single-dose and 82% for the two-dose regimen.

India reports its first confirmed case of Monkeypox, a travel-related infection, in a patient who was isolated with symptoms. The central government assures that the situation is under control and being handled according to established protocols. Public health measures, including contact tracing and monitoring, are in place to prevent further spread. The case is not part of the current public health emergency related to the 'clade 1' strain of Mpox. No broader risk to the public has been detected, and the government is closely monitoring the situation. The patient's identity and travel history have not been disclosed.

India has reported its first Mpox case, with the infected individual confirmed to have contracted the West African clade 2 virus. The patient, who traveled from a country experiencing an Mpox outbreak, showed symptoms upon return and has since been isolated. Authorities have initiated contact tracing and are managing the case according to established protocols. Although Mpox, particularly the new Clade 1b variant in the Democratic Republic of Congo, is causing international concern, this isolated case is not part of the current public health emergency. The patient is stable and poses no immediate risk to the public.

India has identified its first suspected case of mpox, previously known as monkeypox, following the World Health Organisation’s declaration of a Public Health Emergency of International Concern last month. The patient, a young male who recently traveled from a country with active mpox transmission, is currently isolated, and his sample is being tested. The Health Ministry reassured that the risk of a large outbreak in India remains low. Measures, including alerts at entry points and readiness of laboratories, were implemented following the WHO alert. Mpox, caused by the MPXV virus, can lead to severe symptoms, especially in vulnerable populations.

India has reported its first suspected Mpox case, with a young man recently returned from a country experiencing an outbreak. The patient, in stable condition, is undergoing isolation and testing to confirm the infection. Authorities have initiated contact tracing to assess potential risks. The National Centre for Disease Control (NCDC) emphasizes that there is no cause for alarm, stating that measures are in place to manage and mitigate the situation. Mpox, formerly known as monkeypox, is spread through close contact and is currently a concern in several countries, including the DRC.

The Democratic Republic of Congo received its first shipment of 99,000 mpox vaccine doses on September 5, 2024. The vaccines, manufactured by Bavarian Nordic and donated by the EU, arrived in Kinshasa and are aimed at combating a severe outbreak that led the U.N. to declare a global health emergency. Health Minister Samuel Roger Kamba Mulamba announced plans to target high-affected areas such as Equateur and South Kivu. A second delivery on September 7 will bring the total to 200,000 doses. Congo’s vaccination campaign is set to start on October 8.